|4Feb 15, 4:19 PM ET

Adams Jennifer McKie 4

4 · Eton Pharmaceuticals, Inc. · Filed Feb 15, 2024

Insider Transaction Report

Form 4
Period: 2024-02-13
Transactions
  • Award

    Stock Option (Right to buy)

    2024-02-13+30,000133,133 total
    Exercise: $4.42Exp: 2034-02-12Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 13, 2025.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4